Information about Temasek’s involvement in cross-border screening of travellers
Messages being circulated about a cross-border initiative to screen travellers between Singapore and Malaysia for COVID-19 are not correct.
Temasek has not been appointed by the Singapore Government to handle all COVID-19 screening for travellers entering and exiting the country. Temasek Foundation continues to support various efforts to combat the spread of COVID-19 infections.
Affinidi, a company founded by Temasek, has partnered BP Healthcare Group, a swab operator in Malaysia, to issue cryptographically verifiable COVID-19 swab test results. For more details, you may refer to Affinidi’s statement on their website.